Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
4DMedical Ltd ( (AU:4DX) ) just unveiled an announcement.
4DMedical Limited has announced a change in the director’s interest, specifically concerning Dr. Geraldine Bernadette McGinty. She has converted 137,787 Restricted Stock Units into an equivalent number of ordinary shares, resulting in a total holding of 177,787 ordinary shares. This change reflects internal financial adjustments and does not directly impact the company’s operational strategy or market positioning.
More about 4DMedical Ltd
4DMedical Limited is a company within the medical technology industry, focusing on innovative solutions for respiratory diagnostics. The primary products and services include advanced imaging technologies designed to enhance the assessment and management of lung conditions, with a market focus on improving patient outcomes and healthcare efficiencies.
YTD Price Performance: 7.29%
Average Trading Volume: 769,809
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$215.1M
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.
